Are isosorbide dinitrate (ISDN) and isosorbide mononitrate (ISMN) dosed the same?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Isosorbide Dinitrate and Isosorbide Mononitrate Are NOT Dosed the Same

No, isosorbide dinitrate (ISDN) and isosorbide mononitrate (ISMN) are dosed differently and are not interchangeable. The American College of Cardiology explicitly states that isosorbide mononitrate is not recommended for heart failure management, while isosorbide dinitrate is the preferred nitrate formulation 1.

Key Dosing Differences

Isosorbide Dinitrate (ISDN)

  • Starting dose: 20 mg three times daily 1
  • Target dose: 40 mg three times daily 1
  • Frequency: Three times daily dosing required 1
  • Duration of action: Shorter half-life of approximately 36-54 minutes 2, 3

Isosorbide Mononitrate (ISMN)

  • Standard dosing: 20 mg twice daily 4
  • Duration of action: 12-24 hours with extended-release formulations 4
  • Frequency: Once or twice daily dosing 4
  • Half-life: Approximately 4-5 hours, significantly longer than ISDN 5, 6

Why They Differ: Pharmacokinetic Rationale

The dosing differences stem from fundamental pharmacokinetic distinctions between these two nitrates:

  • ISDN undergoes extensive first-pass metabolism (approximately 70% metabolized during first pass through the liver), resulting in only 20-29% bioavailability 7, 3
  • ISMN has 100% bioavailability with no first-pass metabolism, as it is already the active metabolite of ISDN 5, 6
  • ISDN is rapidly metabolized to IS-5-MN (the active mononitrate) and IS-2-MN, with 75% converted to IS-5-MN and 25% to IS-2-MN 3
  • ISMN has an 8-times longer half-life than ISDN (approximately 4-5 hours versus 36-54 minutes), allowing for less frequent dosing 6, 2

Critical Clinical Caveat

The American College of Cardiology specifically does NOT recommend isosorbide mononitrate for heart failure management 1. When prescribing nitrates for heart failure with reduced ejection fraction, particularly in African American patients or those intolerant to ACE inhibitors/ARBs, use isosorbide dinitrate (not mononitrate) in combination with hydralazine 1, 8.

Tolerance Management

Both formulations require a nitrate-free interval of at least 10-14 hours daily to prevent tolerance development 4, 9. However, the three-times-daily dosing of ISDN naturally provides this interval overnight, while ISMN dosing must be specifically timed to ensure adequate nitrate-free periods 4, 9.

Common Pitfall to Avoid

Do not assume these medications are interchangeable or that you can simply convert doses between them based on milligram equivalence. The different pharmacokinetics, bioavailability, and clinical evidence base (particularly for heart failure) make them distinct therapeutic agents requiring different dosing strategies 1, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Isosorbide dinitrate bioavailability, kinetics, and metabolism.

Clinical pharmacology and therapeutics, 1985

Guideline

Isosorbide Mononitrate Mechanism and Side Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate.

European journal of clinical pharmacology, 1981

Guideline

Isosorbide Dinitrate in Heart Failure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Isosorbide Dinitrate Management for Angina Pectoris

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.